ATP7B and Wilson disease: The mutated ATP7B in human patients with WD compromises biliary excretion of copper and inhibits synthesis of holoceruloplasmin, which results in elevated circulating non-ceruloplasmin bound copper that is more capable of reaching extra-hepatic organs (81, 82).